Fiona Fernando

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Treatment-free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations.

Treatment-free remission in CML patients with prior TKI failure is not influenced by previous BCR::ABL1 kinase domain mutations.

Journal: British journal of haematology

Published: June 01, 2026

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

Journal: British journal of haematology

Published: November 21, 2025

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

Journal: EJHaem

Published: June 30, 2025

Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score.

Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score.

Journal: Cardio-oncology (London, England)

Published: May 13, 2024

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Journal: Leukemia

Published: April 24, 2024

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.

Journal: Leukemia & lymphoma

Published: April 23, 2024

Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.

Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.

Journal: American journal of hematology

Published: November 22, 2023

Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance.

Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance.

Journal: Leukemia

Published: September 29, 2023

The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia.

The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia.

Journal: Bone marrow transplantation

Published: October 04, 2022

How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia.

How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia.

Journal: Clinical hematology international

Published: June 22, 2021

Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality.

Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality.

Journal: Leukemia

Published: April 03, 2019

Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.

Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.

Journal: Bone marrow transplantation

Published: July 18, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026